Teva to acquire Allergan for $40B
Teva, Murphy Formalize North America Headquarters Move with Ceremony in Israel - New Jersey Business Magazine
Teva announces debt recycling measures - Globes
Teva stock gains on new growth strategy; Evercore upgrades | Seeking Alpha
TEVA Plunges on Q1 Results - TipRanks.com
teva News and latest stories | The Jerusalem Post
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Why Teva Pharmaceutical Stock Is Sliding Today | The Motley Fool
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva, workers sign accord on Jerusalem factory closure terms | The Times of Israel
Watch CNBC's full interview with Teva CEO Kåre Schultz
Do Analysts Expect Teva Pharmaceutical Industries Ltd (TEVA) Stock to Rise After It Has Gained 10.21% in a Month?
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Articles about Teva Pharmaceuticals, Inc.
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
TEVA.N - | Stock Price & Latest News | Reuters
Teva Pharmaceutical Industries and opioid settlement: What to know
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
FDA approves a generic version of Teva Pharmaceutical's best-selling drug; company shares tumble
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva follows AbbVie to leave top pharma industry group (NYSE:TEVA) | Seeking Alpha
